NCT03036839 Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease Status COMPLETED Phase PHASE2
NCT03032666 Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial Status COMPLETED Phase PHASE4
NCT03025308 Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT03022981 Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection Status COMPLETED Phase PHASE2
NCT03010358 Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03000023 Anticipated and Perceived Benefits Following Hepatitis C Treatment Status COMPLETED Phase N/A
NCT02998320 Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis Status COMPLETED Phase PHASE3
NCT02996682 Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis Status COMPLETED Phase PHASE3
NCT02994056 Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis Status COMPLETED Phase PHASE2
NCT02983617 Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT02983604 GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02979613 Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed Status COMPLETED Phase PHASE3
NCT02968563 Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT02959138 Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02958358 FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan Status WITHDRAWN Phase NA
NCT02957864 Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide Status UNKNOWN Phase PHASE4
NCT02955602 Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) Status COMPLETED Phase PHASE2
NCT02953782 Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2